bioRxivCancer Biology
Frequency-dependent interactions determine outcome of competition between two breast cancer cell lines
A. R. Freischel, M. Damaghi, J. J. Cunningham, A. Ibrahim-Hashim, R. J. Gillies, R. A. Gatenby, J. S. Brown
Abstract
Tumors are highly dynamic ecosystems in which diverse cancer cell subpopulations compete for space and resources. These complex, often non-linear interactions govern continuous spatial and temporal changes in the size and phenotypic properties of these subpopulations. Because intra-tumoral blood flow is often chaotic, competition for resources may be a critical selection factor in progression and prognosis. Here, we quantify resource competition using 3D spheroid cultures with MDA-MB-231 and MCF-7 breast cancer cells. We hypothesized that MCF-7 cells, which primarily rely on efficient aerobic glucose metabolism, would dominate the population under normal pH and low glucose conditions; and MDA-MB-231 cells, which exhibit high levels of glycolytic metabolism, would dominate under low pH and high glucose conditions. In spheroids with single populations, MCF-7 cells exhibited equal or superior intrinsic growth rates (density-independent measure of success) and carrying capacities (density-dependent measure of success) when compared to MDA-MB-231 cells under all pH and nutrient conditions. Despite these advantages, when grown together, MCF-7 cells do not always outcompete MDA-MB-231 cells. MDA-MB-231 cells outcompete MCF-7 cells in low glucose conditions and coexistence is achieved in low pH conditions. Under all conditions, MDA-MB-231 has a stronger competitive effect (frequency-dependent interaction) on MCF-7 cells than vice-versa. This, and the inability of growth rate or carrying capacity when grown individually to predict the outcome of competition, suggests a reliance on frequency-dependent interactions and the need for competition assays. We frame these results in a game-theoretic (frequency-dependent) model of cancer cell interactions and conclude that competition assays can demonstrate critical density-independent, density-dependent and frequency-dependent interactions that likely contribute to in vivo outcomes. HighlightsDemonstrate how mixed-culture spheroids must be used to characterize competition between two cancer cell lines. Competition alters growth dynamics of cancer cells. Competition growth models can be used to quantify density-independent, density-dependent and frequency-dependent effects on competition. Competition affects tumor progression and structure, making it key to understanding tumor development and evolution.
- organism: human
- research focus: cancer & tumor microenvironment
- research focus: cell type annotation
- research focus: clustering
- research focus: differential expression
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Heterotypic competition between cancer cells and hepatocytes generates heterogeneous context-dependent phenotypes
Andrea Spinazzola, Tânia Carvalho, … Eduardo Moreno·bioRxiv·May 15, 2024
- Comparison of the effects of metformin on MDA-MB-231 breast cancer cells in a monolayer culture and in tumour spheroids as a function of nutrient concentrations
M. Bizjak, P. Malavasic, … M. Pavlin·bioRxiv·Jun 20, 2018
- Myc-induced cell mixing is required for competitive tissue invasion and destruction
Eduardo Moreno, Romain Levayer, Barbara Hauert·bioRxiv·Jun 2, 2015
- Cell engulfment defines spatially distinct competitive metabolic niches associated with clinical outcomes in colorectal cancer
Emir Bozkurt, Batuhan Kısakol, … Jochen H.M. Prehn·Cell Death and DifferentiationPeer-reviewed·Jun 30, 2026
- Dynamic flux balance analysis of cancer metabolism using expression-based human cell line models
Liam P. Kelley, Ilija Dukovski, … Daniel Segrè·bioRxiv·Oct 16, 2026
- Interfacial tension and growth both contribute to mechanical cell competition
Léo Valon, Alexis Matamoro‐Vidal, … Romain Levayer·Current BiologyPeer-reviewed·Oct 10, 2025